Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images
Ronald K Lattanze, Medhat M Osman, Kelley A Ryan, Sarah Frye, David W Townsend, Ronald K Lattanze, Medhat M Osman, Kelley A Ryan, Sarah Frye, David W Townsend
Abstract
Background: Infiltrations of 18F-fluorodeoxyglucose (FDG) injections affect positron emission tomography/computed tomography (PET/CT) image quality and quantification. A device using scintillation sensors (Lucerno Dynamics, Cary, NC) provides dynamic measurements acquired during FDG uptake to identify and characterize radioactivity near the injection site prior to patient imaging. Our aim was to compare sensor measurements against dynamic PET image acquisition, our proposed reference in assessing injection quality during the uptake period. Methods: Subjects undergoing routine FDG PET/CT imaging were eligible for this Institutional Review Board approved prospective study. After providing informed consent, subjects had sensors topically placed on their arms. FDG was injected into subjects' veins directly on the PET imaging table. Dynamic images of the injection site were acquired during 45 min of the uptake period. These dynamic image acquisitions and subjects' routine standard static images were evaluated by nuclear medicine physicians for abnormal FDG accumulation near the injection site. Sensor measurements were interpreted independently by Lucerno staff. Dynamic image acquisition interpretation results were compared to the sensor measurement interpretations and to static image interpretations. Results: Twenty-four subjects were consented and enrolled. Data from 21 subjects were gathered. During dynamic image acquisition review, physicians interpreted 4 subjects with no FDG accumulation at the injection site, whereas 17 showed evidence of accumulation. In 10 of the 17 cases that showed FDG accumulation, the FDG presence at the injection site resolved completely during uptake corresponding to venous stasis, the temporary sequestration of blood from circulation. Static image interpretation agreed with dynamic images interpretation in 11/21 (52%) subjects. Sensor measurement interpretations agreed with the dynamic images interpretations in 18/21 (86%) subjects. Conclusions: Sensor measurements can be an effective way to identify and characterize infiltrations and venous stasis. Comparable to an infiltration, venous stasis may produce spurious and clinically meaningful measurement bias and possibly even scan misinterpretation. Since the quality and quantification of PET/CT studies are of clinical importance, sensor measurements acquired during the FDG uptake may prove to be a useful quality control measure to reduce infiltration rates and potentially improve patient care. Registration: Clinicaltrials.gov, Identifier: NCT03041090.
Keywords: FDG; PET/CT; extravasation; infiltrations; quality control.
Figures
References
- Daher N. US Nuclear Medicine and PET Imaging Systems Market (2014).
- Uniform Protocols for Imaging in Clinical Trials FDG PET/CT UPICT V1.0. Available online at: (Accessed March 23, 2018).
- Intersocietal Accreditation Commission The IAC Standards and Guidelines for Nuclear/PET Accreditation. Available online at: (Accessed March 15, 2018).
- American College of Radiology Imaging Network Manual of Procedures Part D: PET-PET/CT Technical Procedures (2013). Available online at: (Accessed March 23, 2018).
- Council of the European Union Council Directive 97/43/EURATOM on Health Protection of Individuals Against the Dangers of Ionizing Radiation in Relation to Medical Exposure. Official Journal of the European Communities; (1997).
- Graham MM, Wahl RL, Hoffman JM, Yap JT, Sunderland JJ, Boellaard R, et al. . Summary of the UPICT protocol for 18F-FDG PET/CT imaging in oncology clinical trials. J Nucl Med. (2015) 56:955–61. 10.2967/jnumed.115.158402
- Hristova I, Boellaard R, Galette P, Shankar LK, Liu Y, Stroobants S, et al. . Guidelines for quality control of PET/CT scans in a multicenter clinical study. EJNMMI Phys. (2017) 4:23. 10.1186/s40658-017-0190-7
- U.S. Department of Health and Human Services Clinical Trial Imaging Endpoint Process Standards Guidance for Industry (2015). Available online at:
- Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. . FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging (2015) 42:328–54. 10.1007/s00259-014-2961-x
- Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. (2015) 38:189–203. 10.1097/NAN.0000000000000100
- Bogsrud TV, Lowe VJ. Normal variants and pitfalls in whole-body PET imaging with 18F FDG. Appl Radiol. (2006) 35:16–30.
- Schaefferkoetter JD, Osman M, Townsend DW. The importance of quality control for clinical PET imaging. J Nucl Med Technol. (2017) 45:265–6. 10.2967/jnmt.117.198465
- Kiser JW, Crowley JR, Wyatt DA, Lattanze RK. Impact of an 18F-FDG PET/CT radiotracer injection infiltration on patient management – a case report. Front Med. (2018) 5:143. 10.3389/fmed.2018.00143
- Osman MM, Muzaffar R, Altinyay ME, Teymouri C. FDG dose extravasations in PET/CT: frequency and impact on SUV measurements. Front Oncol. (2011) 1:41. 10.3389/fonc.2011.00041
- Williams JM, Arlinghaus LR, Rani SD, Shone MD, Abramson VG, Pendyala P, et al. . Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging. Eur J Nucl Med Mol Imaging (2016) 43:2374–80. 10.1007/s00259-016-3477-3
- Krumrey S, Frye R, Tran I, Yost P, Nguyen N, Osman M. FDG manual injection verses infusion system: A comparison of dose precision and extravasation. J Nucl Med. (2009) 50:2031.
- Muzaffar R, Frye SA, McMunn A, Ryan K, Lattanze R, Osman MM. Novel method to detect and characterize (18)F-FDG infiltration at the injection site: a single-institution experience. J Nucl Med Technol. (2017) 45:267–71. 10.2967/jnmt.117.198408
- Hall N, Zhang J, Reid R, Hurley D, Knopp M. Impact of FDG extravasation on SUV measurements in clinical PET/CT. Should we routinely scan the injection site? J Nucl Med. (2006) 47:115P.
- Bains A, Botkin C, Oliver D, Nguyen N, Osman M. Contamination in 18F-FDG PET/CT: an initial experience. J Nucl Med. (2009) 50:2222.
- Silva-Rodriguez J, Aguiar P, Sanchez M, Mosquera J, Luna-Vega V, Cortés J, et al. . Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies. Med Phys. (2014) 41:052502. 10.1118/1.4870979
- Karakatsanis NA, Lodge MA, Tahari AK, Zhou Y, Wahl RL, Rahmim A. Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application. Phys Med Biol. (2013) 58:7391–418. 10.1088/0031-9155/58/20/7391
- Karakatsanis NA, Lodge MA, Zhou Y, Wahl RL, Rahmim A. Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation. Phys Med Biol. (2013) 58:7419–45. 10.1088/0031-9155/58/20/7419
- Taylor AT. Radionuclides in nephrourology, part 1: Radiopharmaceuticals, quality control, and quantitative indices. J Nucl Med. (2014) 55:608–15. 10.2967/jnumed.113.133447
- American College of Radiology ACR Practice Parameter for Communication of Diagnostic Imaging Findings. Available online at: (Accessed March 28, 2018).
- Niederkohr RD, Greenspan BS, Prior JO, Schöder H, Seltzer MA, Zukotynski KA, et al. . Reporting guidance for oncologic 18F-FDG PET/CT imaging. J Nucl Med. (2013) 54:756–61. 10.2967/jnumed.112.112177
- Lemmers NW, Gels ME, Sleijfer DT, Plukker JT, van der Graaf WT, de Langen ZJ, et al. . Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol. (1996) 14:2916–22.
- Boyle DM, Engelking C. Vesicant extravasation: myths and realities. Oncol Nurs Forum. (1995) 22:57–67.
- Wang CL, Cohan RH, Ellis JH, Adusumilli S, Dunnick NR. Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections. Radiology (2007) 243:80–7. 10.1148/radiol.2431060554
- Dykes TM, Bhargavan-Chatfield M, Dyer RB. Intravenous contrast extravasation during CT: a national data registry and practice quality improvement initiative. J Am Coll Radiol. (2015) 12:183–91. 10.1016/j.jacr.2014.07.021
- Kim SJ, Yi HK, Lim CH, et al. . Intra-patient Variability of FDG standardized uptake values in mediastinal blood pool, liver, and myocardium during R-CHOP chemotherapy in patients with diffuse large B-cell lymphoma. Nucl Med Mol Imaging. (2016) 50:300–7. 10.1007/s13139-016-0432-y
Source: PubMed